[1] LIAN Z P，XIE Y K，LU Y X，et al. Trends in the

major causes of death in China，1982-2010[J]. Chin

Med J（Engl），2014，127（4）：777-781.

[2] 王陇德，刘建民，杨弋，等. 《中国脑卒中防治报告

2017》概要[J]. 中国脑血管病杂志，2018，15（11）：

611-616.

[3] WANG W Z，JIANG B，SUN H X，et al. Prevalence，

incidence，and mortality of stroke in China clinical

perspective[J]. Circulation，2017，135（8）：759-771.

[4] ZHOU M G，WANG H D，ZENG X Y，et al.

Mortality，morbidity，and risk factors in China and

its provinces，1990-2017：a systematic analysis for

the Global Burden of Disease Study 2017[J]. Lancet，

2019，394（10204）：1145-1158.

[5] XIE X R，CHEN L，ZENG J S，et al. Clinical

features and biological markers of lung cancerassociated

stroke[J]. J Int Med Res，2016，44（6）：

1483-1491.

[6] CHEN Y，QIN Q X，QIN C，et al. Specific

biomarkers of prostate cancer-associated ischemic

stroke：a case-control study[J/OL]. Med Sci Monit，

2019，25：5536-5542[2020-10-20]. https：//doi.org/10.

12659/MSM.917970.

[7] 林佳才，伍思婷，徐睿，等. 肺癌合并急性缺血性脑卒

中发作患者的临床分析[J]. 中国医药，2020，15（2）：

231-234.

[8] SEOK J M，KIM S G，KIM J W，et al. Coagulopathy

and embolic signal in cancer patients with ischemic

stroke[J]. Ann Neurol，2010，68（2）：213-219.

[9] WALL J G，WEISS R B，NORTON L，et al. Arterial

thrombosis associated with adjuvant chemotherapy

for breast carcinoma：a cancer and leukemia group B

study[J]. Am J Med，1989，87（5）：501-504.

[10] LIANG L W，PEREZ A R，CANGEMI N A，et

al. Nonbacterial thrombotic endocarditis with

embolic cerebral vascular accidents in a patient with

advanced，recurrent clear cell carcinoma of the ovary：

a case report[J/OL]. Gynecol Oncol Rep，2016，16：

25-27[2020-10-20]. https：//doi.org/10.1016/j.gore.

2016.03.003.

[11] HARRIS K M. A case of confirmed nonbacterial

thrombotic endocarditis with correlative

transesophageal echocardiography findings[J].

Echocardiography，2000，17（1）：45-48.

[12] SAYNAK M，COSAR-ALAS R，YURUTCALOGLU

V，et al. Chemotherapy and

cerebrovascular disease[J]. J BUON，2008，13（1）：

31-36.

[13] GRISOLD W，OBERNDORFER S，STRUHAL W.

Stroke and cancer：a review[J]. Acta Neurol Scand，

2009，119（1）：1-16.

[14] DORRESTEIJN L D，KAPPELLE A C，BOOGERD

W，et al. Increased risk of ischemic stroke after

radiotherapy on the neck in patients younger than 60

years[J]. J Clin Oncol，2002，20（1）：282-288.

[15] WILBERS J，DORRESTEIJN L D，HAAST R，et

al. Progression of carotid intima media thickness

after radiotherapy：a long-term prospective cohort

study[J]. Radiother Oncol，2014，113（3）：359-363.

[16] LORENZ M W，MARKUS H S，BOTS M L，et

al. Prediction of clinical cardiovascular events with

carotid intima-media thickness：a systematic review

and meta-analysis[J]. Circulation，2007，115（4）：

459-467.

[17] JESPERSEN C G，NØRGAARD M，BORRE

M. Androgen-deprivation therapy in treatment of

prostate cancer and risk of myocardial infarction and

stroke：a nationwide Danish population-based cohort

study[J/OL]. Eur Urol，2013，64（3）：e61[2020-10-

20]. https：//doi.org/10.1016/j.eururo.2013.04.016.

[18] TAE B S，JEON B J，CHOI H，et al. Is androgen

deprivation therapy associated with cerebral

infarction in patients with prostate cancer? A Korean

nationwide population-based propensity score

matching study[J]. Cancer Med，2019，8（9）：4475-4483.

[19] ESTEVA F J，HORTOBAGYI G N. Comparative

assessment of lipid effects of endocrine therapy

for breast cancer：implications for cardiovascular

disease prevention in postmenopausal women[J].

Breast，2006，15（3）：301-312.

[20] FISHER B，COSTANTINO J P，WICKERHAM D

L，et al. Tamoxifen for prevention of breast cancer：

report of the National Surgical Adjuvant Breast and

Bowel Project P-1 Study[J]. J Natl Cancer Inst，1998，

90（18）：1371-1388.

[21] NAVI B B，REINER A S，KAMEL H，et al.

Association between incident cancer and subsequent

stroke[J]. Ann Neurol，2015，77（2）：291-300.

[22] HSU C W，HUANG Y B，KUO C C，et al.

Evaluating the primary prevention of ischemic stroke

of oral antithrombotic therapy in head and neck

cancer patients with radiation therapy[J/OL]. Biomed

Res Int，2016，2016：6205158[2020-10-20].

https：//doi.org/10.1155/2016/6205158.

[23] NAM K W，KIM C K，KIM T J，et al. Treatment

of cryptogenic stroke with active cancer with a new

oral anticoagulant[J]. J Stroke Cerebrovasc Dis，2017，

26（12）：2976-2980.

[24] JANG H，LEE J J，LEE M J，et al. Comparison of

enoxaparin and warfarin for secondary prevention

of cancer-associated stroke[J/OL]. J Oncol，2015，

2015：502089[2020-10-20]. https：//doi.org/10.

1155/2015/502089.

[25] MURTHY S B，KARANTH S，SHAH S，et al.

Thrombolysis for acute ischemic stroke in patients

with cancer：a population study[J]. Stroke，2013，44

（12）：3573-3576.

[26] WEEDA E R，BOHM N. Association between

comorbid cancer and outcomes among admissions

for acute ischemic stroke receiving systemic

thrombolysis[J]. Int J Stroke，2019，14（1）：48-52.

[27] VELANDER A J，DEANGELIS L M，NAVI B B.

Intracranial hemorrhage in patients with cancer[J].

Curr Atheroscler Rep，2012，14（4）：373-381.

[28] YONEDA Y，FUKUDA A，YAMAZAKI T，et

al. Intravenous tissue plasminogen activator for an

ischemic stroke with occult double primary cancer[J].

Case Rep Neurol，2014，6（3）：238-242.

[29] 张勇，覃雅倩，银铎. 他汀类药物抗肿瘤作用机制的

研究进展[J]. 肿瘤研究与临床，2018，30（10）：710-

713.

[30] KIM Y S，PARK M S，LEE J H，et al. Effect of

statins on survival following stroke in patients with

cancer[J/OL]. Front Neurol，2018，9：205[2020-10-

20]. https：//doi.org/10.3389/fneur.2018.00205.